Empowered Funds LLC Has $950,000 Stake in MetLife, Inc. (NYSE:MET)

Empowered Funds LLC grew its stake in MetLife, Inc. (NYSE:METFree Report) by 11.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,607 shares of the financial services provider’s stock after acquiring an additional 1,199 shares during the period. Empowered Funds LLC’s holdings in MetLife were worth $950,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in MET. MeadowBrook Investment Advisors LLC lifted its stake in shares of MetLife by 244.4% in the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. raised its position in MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares during the last quarter. Peterson Financial Group Inc. acquired a new stake in shares of MetLife during the third quarter valued at about $30,000. Retirement Wealth Solutions LLC bought a new position in MetLife in the 4th quarter valued at approximately $32,000. Finally, Fortitude Family Office LLC grew its holdings in MetLife by 177.3% during the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 266 shares during the last quarter. 94.99% of the stock is owned by institutional investors.

MetLife Price Performance

MET opened at $81.78 on Tuesday. The stock has a market capitalization of $56.63 billion, a P/E ratio of 13.70, a PEG ratio of 0.64 and a beta of 1.07. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a 12-month low of $67.30 and a 12-month high of $89.05. The stock has a 50-day moving average price of $83.41 and a 200-day moving average price of $81.11.

MetLife (NYSE:METGet Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. Equities analysts predict that MetLife, Inc. will post 9.63 earnings per share for the current fiscal year.

MetLife Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.67%. The ex-dividend date is Tuesday, February 4th. MetLife’s dividend payout ratio is 36.52%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on MET shares. Keefe, Bruyette & Woods cut their price target on shares of MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a report on Wednesday, February 12th. BMO Capital Markets initiated coverage on MetLife in a research report on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price target on the stock. Barclays cut their price objective on MetLife from $96.00 to $95.00 and set an “overweight” rating on the stock in a research note on Friday, February 7th. TD Cowen raised their price target on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday, November 27th. Finally, StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $92.17.

Check Out Our Latest Research Report on MET

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.